- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Pan-cancer analysis of the prognostic and immunological role of PAQR4 ; volume:12 ; number:1 ; day:8 ; month:12 ; year:2022 ; pages:1-16 ; date:12.2022
Scientific reports ; 12, Heft 1 (8.12.2022), 1-16, 12.2022
- Urheber
-
Wang, Kaibin
Meng, Jinhuan
Wang, Xudong
Yan, Mo
Liu, Shuaibing
Yang, Shaobo
Xu, Shengxian
Liu, Dongze
Li, Changying
Yang, Kuo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-25220-3
- URN
-
urn:nbn:de:101:1-2023021809030408446574
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wang, Kaibin
- Meng, Jinhuan
- Wang, Xudong
- Yan, Mo
- Liu, Shuaibing
- Yang, Shaobo
- Xu, Shengxian
- Liu, Dongze
- Li, Changying
- Yang, Kuo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Prognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer
The prognostic and immune significance of SLAMF9 in pan-cancer and validation of its role in colorectal cancer
Co-expression of CMTM6 and PD-L1: a novel prognostic indicator of gastric cancer
Pan-cancer analysis of COL15A1: an immunological and prognostic biomarker
MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
A comprehensive prognostic and immunological implications of PFKP in pan-cancer
Comprehensive pan-cancer analysis of STAT3 as a prognostic and immunological biomarker
SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer
Prognostic value and immunological role of PD-L1 gene in pan-cancer
Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
PHF5A is a potential diagnostic, prognostic, and immunological biomarker in pan-cancer
Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker
Prognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer
The prognostic and immune significance of SLAMF9 in pan-cancer and validation of its role in colorectal cancer
Co-expression of CMTM6 and PD-L1: a novel prognostic indicator of gastric cancer
Pan-cancer analysis of COL15A1: an immunological and prognostic biomarker
MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
A comprehensive prognostic and immunological implications of PFKP in pan-cancer
Comprehensive pan-cancer analysis of STAT3 as a prognostic and immunological biomarker
SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer
Prognostic value and immunological role of PD-L1 gene in pan-cancer
Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
PHF5A is a potential diagnostic, prognostic, and immunological biomarker in pan-cancer
Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker
Prognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer
The prognostic and immune significance of SLAMF9 in pan-cancer and validation of its role in colorectal cancer
Co-expression of CMTM6 and PD-L1: a novel prognostic indicator of gastric cancer
Pan-cancer analysis of COL15A1: an immunological and prognostic biomarker
MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
A comprehensive prognostic and immunological implications of PFKP in pan-cancer
Comprehensive pan-cancer analysis of STAT3 as a prognostic and immunological biomarker
SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer
Prognostic value and immunological role of PD-L1 gene in pan-cancer
Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
PHF5A is a potential diagnostic, prognostic, and immunological biomarker in pan-cancer